Catalyst Wire Dossier Catalyst Wire Dossier

Encaleret

encaleret · Calcilytix Therapeutics, Inc., a BridgeBio company
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Encaleret, covering 2024-11-19 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1) [Phase 2, Phase 3]

See pricing